Xenon Pharmaceuticals (XENE) EBT Margin Growth (1y) (2014 - 2022)
Xenon Pharmaceuticals (XENE) EBT Margin Growth (1y) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -2.84 Mn |
| Jun 30, 2022 | -481,394.00 |
| Mar 31, 2022 | 13,440.00 |
| Dec 31, 2021 | -43,157.00 |
| Sep 30, 2021 | -5,443.00 |
| Jun 30, 2021 | -100,498.00 |
| Mar 31, 2021 | -25,754.00 |
| Dec 31, 2020 | 10,325.00 |
| Sep 30, 2020 | 11,511.00 |
| Dec 31, 2017 | -4.81 Mn |
| Sep 30, 2017 | -147,982.00 |
| Jun 30, 2017 | -5.04 Mn |
| Mar 31, 2017 | -4.81 Mn |
| Dec 31, 2016 | -245,930.00 |
| Sep 30, 2016 | -173,139.00 |
| Jun 30, 2016 | -152,057.00 |
| Mar 31, 2016 | -77,571.00 |
| Dec 31, 2015 | 17,905.00 |
| Sep 30, 2015 | -8,276.00 |
| Jun 30, 2015 | -1,965.00 |